Norwood Systems Ltd (ASX:NOR) Secures $2.98M Voicemail Contract with Optus
Norwood Systems Ltd (ASX:NOR) signs a $2.98 million, five-year contract with Optus to replace their voicemail system with the CogVoice platform.
Tag: Industry-Specific News
KGL Resources (ASX:KGL) Reports Final Results from 2024 Drilling Program
KGL Resources (ASX:KGL) reports final results from its 2024 drilling program, showcasing significant copper intersections and resource expansions across the Jervois Project.
AXP Energy Limited (ASX:AXP) Scales Up Gas-to-Power Operations with BitFuFu Partnership
AXP Energy Limited (ASX:AXP) partners with BitFuFu to expand gas-to-power operations, targeting 25MW by CY2025 for bitcoin mining growth.
AVITA Medical (ASX:AVH) Announces New Manufacturing and Distribution Agreements
AVITA Medical (ASX:AVH) partners with Stedical Scientific to enhance production and distribution of PermeaDerm wound matrix.
Navigator Global Investments Limited (ASX:NGI) Acquires 23.5% Stake in 1315 Capital
Navigator Global Investments Limited (ASX:NGI) acquires a 23.5% stake in healthcare investment firm 1315 Capital.
Global Health Limited (ASX:GLH) Secures $1 Million Contract with Youturn
Global Health Limited (ASX:GLH) secures a $1 million contract with Youturn to enhance digital solutions for youth mental health services.
Rimfire Pacific Mining (ASX:RIM) Commences Scandium Drilling Program
Rimfire Pacific Mining (ASX:RIM) begins its first dedicated scandium drilling program at Currajong Prospect, aiming to establish a maiden Mineral Resource.
Meridian Energy Limited (ASX:MEZ) Releases February Operating Report
Meridian Energy Limited (ASX:MEZ) reports February 2025 with lowest start to the year in inflows and decreased hydro storage levels.
BetMakers Technology Group Ltd (ASX:BET) Renews Partnership with UK Tote Group
BetMakers Technology Group Ltd (ASX:BET) renews its Global Tote partnership with UK Tote Group, securing the Quantum software as the core wagering platform.
InhaleRx Limited (ASX:IRX) Executes Study Order for Phase 2 IRX-211 Trial
InhaleRx Limited (ASX:IRX) executes Study Order for Phase 2 IRX-211 trial targeting breakthrough cancer pain.